Morphological characteristics of eyes with neovascular age-related macular degeneration and good long-term visual outcomes after anti-VEGF therapy

Mengyuan Fang, Karntida Chanwimol, Jyotsna Maram, Ghazala A. Datoo O’Keefe, Charles C. Wykoff, David Sarraf, Asha Brown, Shaun Ian Retief Lampen, Brenda Zhou, Alexander M. Rusakevich, Srini Vas Sadda

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Purpose To analyse the morphological characteristics of eyes with neovascular age-related macular degeneration (AMD) with good long-term visual acuity after anti-VEGF (vascular endothelial growth factor) therapy. Methods Retrospective, observational study of 175 patients with neovascular AMD with >5 years of followup after initiating anti-VEGF therapy. Spectral-domain optical coherence tomography images were assessed for thickness of pigment epithelial detachment (PED), subretinal hyper-reflective material (SHRM), subretinal fluid and subfoveal choroidal, as well as the integrity of the outer retinal bands. Results The final analysis cohort included 203 eyes (175 patients) followed for a mean of 7.84±1.70 years (range: 5–11). The maximum PED thickness in the foveal central subfield (FCS) was significantly lower (p<0.001) in the poor vision group (13.11 μm) compared with the intermediate (86.25 μm) or good (97.92 μm) vision groups, respectively. In contrast, the maximum thickness of SHRM in the FCS was significantly thicker (p<0.001) in eyes with poor vision (149.46 μm) compared with eyes with intermediate vision (64.37 μm) which in turn were significantly thicker (p<0.001) than eyes with good vision (9.35 μm). The good vision group also had better continuity of all outer retinal bands (external limiting membrane, ellipsoid zone, and retinal pigment epithelium) compared with the other two groups (all p<0.001). Conclusion A thicker PED and thinner SHRM were correlated with better vision in eyes with neovascular AMD following long-term anti-VEGF therapy. If replicated in future prospective studies, these findings may have implications for design of optimal anatomic endpoints for neovascular AMD treatment.

Original languageEnglish (US)
Pages (from-to)399-405
Number of pages7
JournalBritish Journal of Ophthalmology
Volume107
Issue number3
DOIs
StatePublished - Mar 2023

Keywords

  • imaging
  • retina
  • treatment other
  • Vascular Endothelial Growth Factor A
  • Intravitreal Injections
  • Tomography, Optical Coherence
  • Humans
  • Wet Macular Degeneration/diagnosis
  • Visual Acuity
  • Retinal Detachment/drug therapy
  • Angiogenesis Inhibitors/therapeutic use
  • Ranibizumab/therapeutic use
  • Retrospective Studies
  • Fluorescein Angiography

ASJC Scopus subject areas

  • Sensory Systems
  • Cellular and Molecular Neuroscience
  • Ophthalmology

Fingerprint

Dive into the research topics of 'Morphological characteristics of eyes with neovascular age-related macular degeneration and good long-term visual outcomes after anti-VEGF therapy'. Together they form a unique fingerprint.

Cite this